Torigen Pharmaceuticals
Dr. Clauson graduated from the University of Michigan with a Ph.D. and M.S. in Pharmaceutical Science. He is an experienced immunologist whose past research focused on the development of novel biomaterials and vaccines for cancer immunotherapy. Dr. Clauson will be responsible for establishing and maintaining all research activities at Torigen, including pre-clinical and clinical analysis of current and future products.
This person is not in any offices
Torigen Pharmaceuticals
1 followers
Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign.